DSP-3025 A Phase 1 Study of Healthy Male Volunteers
NCT01124396 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 24
Last updated 2022-04-12
Summary
Investigate safety/tolerability after repeated weekly doses intranasal administration of DSP-3025 comparator placebo to healthy male volunteers
Conditions
- Healthy
Interventions
- DRUG
-
DSP-3025
- DRUG
Sponsors & Collaborators
-
Sumitomo Pharma Co., Ltd.
lead INDUSTRY
Eligibility
- Min Age
- 20 Years
- Max Age
- 39 Years
- Sex
- MALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2010-04-30
- Primary Completion
- 2010-08-31
- Completion
- 2012-04-30
Countries
- Japan
Study Locations
More Related Trials
-
A Study of JNJ-61393215 in Healthy Japanese Male Participants
NCT04713930 ·Status: COMPLETED ·Phase: PHASE1
-
A Single and Multiple Oral Dose Study and a Treatment Schedule-finding Study in Non-elderly, Healthy Subjects
NCT02500953 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Safety of ASP2408 After Subcutaneous Administration to Healthy Male Subjects
NCT02140125 ·Status: COMPLETED ·Phase: PHASE1
-
A Single Dose Study of DWP10292 in Healthy Male Subjects
NCT01423526 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of JNJ-67953964 in Healthy Japanese Adult Male Participants
NCT04791332 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of JNJ-39393406 in Healthy Participants
NCT02023255 ·Status: COMPLETED ·Phase: PHASE1
-
Phase 1 TAK-906 Single and Multiple Ascending Dose Study in Japanese Healthy Male Participants
NCT03237156 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Assess Safety and Tolerability of ASP1941 After Single and Repeated Administration in Healthy Subjects
NCT01121198 ·Status: COMPLETED ·Phase: PHASE1
-
Clinical Trial to Investigate the Safety, Tolerability, and Pharmacokinetics of DWP09031
NCT01522586 ·Status: TERMINATED ·Phase: PHASE1
-
A Phase 1 Clinical Study to Investigate the Pharmacokinetics and Safety/Tolerability of SA001 in Healthy Male Volunteers
NCT02470286 ·Status: COMPLETED ·Phase: PHASE1
-
Phase I Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SP-8008
NCT04770194 ·Status: COMPLETED ·Phase: PHASE1
-
Single Ascending Dose Study Using DS-1971 to Assess Safety, Tolerability, and Pharmacokinetics in Healthy Participants.
NCT02107885 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Investigate Safety, Tolerability, and Pharmacokinetics of DSTA4637S in Healthy Volunteers
NCT02596399 ·Status: COMPLETED ·Phase: PHASE1
-
Phase I Clinical Study to Investigate the Pharmacokinetics and Safety/Tolerability of DA-7218 in Healthy Male Volunteers
NCT02097043 ·Status: COMPLETED ·Phase: PHASE1
-
Phase 1a Study in Healthy Participants
NCT05953506 ·Status: UNKNOWN ·Phase: PHASE1
-
A Study to Evaluate Safety and Tolerability After Oral Dosing of AZD1656 in Healthy Volunteers
NCT00726427 ·Status: COMPLETED ·Phase: PHASE1
-
Clinical Pharmacology Study of MT-3534 in Healthy Adult Male Volunteers
NCT06482346 ·Status: COMPLETED ·Phase: PHASE1
-
This Study Tests the Safety, Tolerability and How Different Doses of BI 1265162 Are Taken up in the Body of Healthy Men
NCT03349723 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of JNJ-40411813 in Healthy Japanese Male Participants
NCT04677530 ·Status: COMPLETED ·Phase: PHASE1
-
Study of Single-Ascending Doses of DS-6016a in Healthy Japanese Subjects
NCT04818398 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase I Study of TS-172 in Healthy Adult Subjects (Single and Multiple Doses)
NCT04979572 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability and Pharmacokinetics of Single and Multiple Oral Administration of HS-10356 in Healthy Volunteers
NCT04652297 ·Status: UNKNOWN ·Phase: PHASE1
-
Safety, Tolerability and Pharmacokinetics of BI 1026706 in Healthy Chinese and Japanese Male Volunteers
NCT02652416 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate Safety and Tolerability of BMN 111 Administered to Healthy Adult Volunteers
NCT01590446 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Following Subcutaneous Injection of JNJ-64304500 in Healthy Japanese and Caucasian Male Participants
NCT03002025 ·Status: COMPLETED ·Phase: PHASE1